Cellular localization of complement C3 and C4 transcripts in intestinal specimens from patients with Crohn's disease

Clinical and Experimental Immunology

Volumn 120, Issue 1, 2000, Pages 30-37

  Laufer, J ^a   Oren, R ^a   Goldberg, I ^a   Horwitz, A ^a   Kopolovic, J ^a   Chowers, Y ^a   Passwell, J H ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Complement; Crohn's disease; Gene expression; Human; Intestine

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4;

ARTICLE; CELLULAR DISTRIBUTION; COLON CROHN DISEASE; COMPLEMENT ACTIVATION; CYTOKINE RELEASE; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GIANT CELL; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTESTINE EPITHELIUM; LAMINA PROPRIA; MULTINUCLEAR CELL; PATHOGENESIS; PRIORITY JOURNAL; TISSUE SECTION;

EID: 0034077161     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01168.x     Document Type: Article

References (42)

1. Schreiber S, Raedler A, Stenson WF, McDermott RP. The role of the mucosal immune system in inflammatory bowel disease. Gastroenterol Clinic North Am 1992; 21:451-2.
2. Mayer L. Mucosal immune system in inflammatory bowel disease. In: MacDermott RP, Stenson WF, eds. Inflammatory bowel disease. New York: Elsevier, 1992:53-75.
3. Podolsky DK. Inflammatory bowel disease. N Engl J Med 1991; 325:928-37.
4. Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S. Spontaneous development of inflammatory bowel diseases in T cell receptor mutant mice. Cell 1993; 75:275-82.
5. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with disrupted interleukin-2 gene. Cell 1993; 75:253-61.
6. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75:263-74.
7. Halstensen TS, Mollnes TE, Fausa O, Brandtzaeg P. Deposits of terminal complement complex (TCC) in muscularis mucosae and submucosal vessels in ulcerative colitis and Crohn's disease of the colon. Gut 1989; 30:361-6.
8. Halstensen TS, Mollnes TE, Brandtzaeg P. Persistent complement activation in submucosal blood vessels of active inflammatory bowel disease: immunohistochemical evidence. Gastroenterology 1989; 97:10-19.
9. r 40 kD putative autoantigen in ulcerative colitis. Gut 1993; 34:650-7.
10. Ahrenstedt O, Knutson L, Nilsson B, Nillson-Ekdahl K, Odlind B, Hallgren R. Enhanced local production of complement components in the small intestines of patients with Crohn's disease. N Engl J Med 1990; 322:1345-9.
11. Witte DP, Welch TR, Beischel LS. Detection and cellular localization of human C4 gene expression in the renal tubular epithelial cells and other extrahepatic epithelial sources. Am J Pathol 1991; 139:717-24.
12. Molmenti EP, Ziambaras T, Perlmutter DH. Evidence for an acute phase response in human intestinal epithelial cells. J Biol Chem 1993; 268:14116-24.
13. Andoh A, Fujiyama Y, Bamba T, Hosoda S. Differential cytokine regulation of complement C3, C4 and factor B synthesis in human intestinal epithelial cell line, Caco-2. J Immunol 1993; 151:4239-47.
14. De Bruijn MHL, Fey GA. Human complement component C3: cDNA coding sequence and derived primary structure. Proc Natl Acad Sci USA 1985; 82:708-12.
15. Whitehead AS, Goldberger G, Woods DE, Markham AF, Colten HR. Use of a cDNA clone for the fourth component of human complement (C4) for analysis of a genetic deficiency of C4 in guinea pig. Proc Nat Acad Sci USA 1983; 80:5387-91.
16. Williamson DG. In situ hybridization: a practical approach. Oxford: University Press, 1992.
17. Hsu SM, Raine L, Fanger H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29:577-88.
18. Santos LMB, Lider O, Audette J, Khoury SJ, Weiner HL. Characterization of immunomodulatory properties and accessory cell function of small intestinal epithelial cells. Cell Immunol 1990; 127:26-34.
19. Shirota K, LeDuy L, Yuan SY et al. Interleukin-6 and its receptor are expressed in human intestinal epithelial cells. Virchows Arch [B] 1990; 58:303-8.
20. Koyama SY, Podolsky DK. Differential expression of transforming growth factor-α and β in rat intestinal epithelial cells. J Clin Invest 1989; 83:1768-73.
21. Ferraris L, Karmeli F, Eliakim R, Klein J, Fiocchi C, Rachmilewitz D. Intestinal epithelial cells contribute to the enhanced generation of platelet activating factor in ulcerative colitis. Gut 1993; 34:665-8.
22. Laufer J, Boichis H, Farzam N, Passwell JH. IgA and IgG immune complexes increase human macrophage C3 biosynthesis. Immunology 1995; 84:207-12.
23. Alpert SE, Auerbach HS, Cole FS, Colten HR. Macrophage maturation: differences in complement secretion by marrow, monocyte, and tissue macrophages detected with an improved hemolytic plaque assay. J Immunol 1983; 130:102-7.
24. Murch AR, Grounds MD, Marshall CA, Papadimitriou JM. Direct evidence that inflammatory multinucleated giant cells form by fusion. J Pathol 1981; 137:177-80.
25. Van der Rhee HJ, van der Burgh-de Winter CP, Daems WT. The differentiation of monocytes into macrophages, epithelioid cells and multi-nucleated giant cells in subcutaneous granulomas. Cell Tissue Res 1979; 197:355-78.
26. Kreipe H, Radzun HJ, Rudolph P, Barth J, Hansmann ML, Heidron K, Parawaresch MR. Multinucleated giant cells generated in vitro. Terminally differentiated macrophages with down-regulated c-fms expression. Am J Pathol 1988; 130:232-43.
27. Weinberg JB, Hobbs MM, Misukonis MA. Recombinant human gamma-interferon induces human monocyte polykaryon formation. Proc Natl Acad Sci USA 1984; 81:4554-7.
28. Fais S, Pallone F. Inability of normal human intestinal macrophages to form multinucleated giant cells in response to cytokines. Gut 1995; 37:798-801.
29. Wasserman SI. Mediators of immediate hypersensitivity. J Allergy Clin Immunol 1983; 72:101-19.
30. Wershil BK, Galli SJ. Gastrointestinal mast cells: new approaches for analyzing their function in vivo. Gastoenterol Clin North Am 1991; 20:613-27.
31. Bradding P, Roberts JA, Britten KM et al. Interleukin-4,-5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10:471-80.
32. Dvorak AM, Monahan RA, Osage JE, Dickersin GR. Crohn's disease: transmission electron microscopic studies II. Immunologic inflammatory response. Alterations of mast cells, basophils, eosinophils, and micro-vasculature. Hum Pathol 1980; 11:606-19.
33. Hiatt RB, Katz L. Mast cells in inflammatory conditions of the gastrointestinal tract. Am J Gastroenterol 1962; 37:541-5.
34. Schwartz LB, Kawahara MS, Hugli TE, Vik D, Fearon DT, Austen KF. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. J Immunol 1983; 130:1891-5.
35. Mousli M, Hugli TE, Landry Y, Bronner C. A mechanism of action for anaphylatoxin C3a stimulation of mast cells. J Immunol 1992; 148:2456-61.
36. Ito BR, Engler RL, del Balzo U. Role of cardiac mast cells in complement C5a-induced myocardial ischemia. Am J Physiol 1993; 264: H1346-54.
37. Moore WEC, Holdeman LV. Discussion of current bacteriologic investigations of the relationship between intestinal flora, diet and colon cancer. Cancer Res 1975; 35:3418-20.
38. Chan AC, Karp DR, Shreffler DC, Atkinson JP. The 20 faces of the fourth component of complement. Immunol Today 1984; 5:200-3.
39. Damerau B. Biological activities of complement-derived peptides. Rev Physiol Biochem Pharmacol 1987; 108:151-206.
40. Tsuruta T, Yamamoto T, Matsubara S, Nagasawa S, Tanase S, Tanaka JJ, Takagi K, Kambara T. Novel function of C4a anaphylatoxin. Release from monocytes of protein which inhibits monocyte chemotaxis. Am J Pathol 1993; 142:1848-57.
41. 2 generation by C4a. Immunol Letters 1993; 36:301-4.
42. Prodeus AP, Goerg S, Shen LM, Pozdnyakova OO, Chu L, Alicot EM, Goodnow CC, Carroll MC. A critical role for complement in maintenance of self-tolerance. Immunity 1998; 9:721.